Related references
Note: Only part of the references are listed.Tenascin C: A Potential Biomarker for Predicting the Severity of Coronary Atherosclerosis
Wen Gao et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)
Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes
Katherine N. Bachmann et al.
DIABETOLOGIA (2018)
Validation of the ORIGIN Cardiovascular Biomarker Panel and the Value of Adding Troponin I in Dysglycemic People
Hertzel C. Gerstein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy
Gema Fernandez-Juarez et al.
NEPHROLOGY (2017)
Serum Angiopoietin-Like Protein 2 Is a Novel Risk Factor for Cardiovascular Disease in the Community: The Hisayama Study
Jun Hata et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients
Barnabas Gellen et al.
DIABETOLOGIA (2016)
Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy
Tetsuro Yokokawa et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)
Neil A. Turner
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes
Bernt Johan von Scholten et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia
Hertzel C. Gerstein et al.
CIRCULATION (2015)
Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus
Derya Ozturk et al.
CORONARY ARTERY DISEASE (2015)
Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes
Helen C. Looker et al.
DIABETOLOGIA (2015)
Impact of serum tenascin-C on the aortic healing process during the chronic stage of type B acute aortic dissection
Toshihiro Nozato et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)
Karen A. Hicks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
A new predictor of mortality in hemodialysis patients; Tenascin-C
Sukru Ulusoy et al.
LIFE SCIENCES (2015)
Serum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart Failure
Chi-Lun Huang et al.
PLOS ONE (2015)
The extracellular matrix and insulin resistance
Ashley S. Williams et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study
Nathalie Neirynck et al.
PLOS ONE (2015)
Tenascin-C: Form versus function
Sean P. Giblin et al.
CELL ADHESION & MIGRATION (2015)
External Validation of the UKPDS Risk Engine in Incident Type 2 Diabetes: A Need for New Type 2 Diabetes-Specific Risk Equations
Christian A. Bannister et al.
DIABETES CARE (2014)
Association of Serum Concentration of TNFR1 With All- Cause Mortality in Patients With Type 2 Diabetes and Chronic Kidney Disease: Follow- up of the SURDIAGENE Cohort
Pierre-Jean Saulnier et al.
DIABETES CARE (2014)
N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
Anna H. Price et al.
DIABETOLOGIA (2014)
Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease
A. E. Berezin et al.
ATHEROSCLEROSIS (2013)
UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82
A. J. Hayes et al.
DIABETOLOGIA (2013)
Diabetes-induced morphological, biomechanical, and compositional changes in ocular basement membranes
Margaret To et al.
EXPERIMENTAL EYE RESEARCH (2013)
Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1
Jung Eun Lee et al.
PLOS ONE (2013)
Tenascin-C in Cardiovascular Tissue Remodeling - From Development to Inflammation and Repair
Kyoko Imanaka-Yoshida
CIRCULATION JOURNAL (2012)
Prognostic Value of Serum Tenascin-C Levels on Long-Term Outcome After Acute Myocardial Infarction
Akira Sato et al.
JOURNAL OF CARDIAC FAILURE (2012)
High circulating levels of large splice variants of tenascin-C is associated with mortality and cardiovascular disease in chronic kidney disease patients
Sophie Liabeuf et al.
ATHEROSCLEROSIS (2011)
Advances in tenascin-C biology
Kim S. Midwood et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
DAMPening Inflammation by Modulating TLR Signalling
A. M. Piccinini et al.
MEDIATORS OF INFLAMMATION (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects -: Results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Raimpril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies
Samy Hadjadj et al.
DIABETES CARE (2008)
Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction
Akira Sato et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Tenascins: regulation and putative functions during pathological stress
R Chiquet-Ehrismann et al.
JOURNAL OF PATHOLOGY (2003)
Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease
JH Hörstrup et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Share Paper
